개 관절염 치료 시장은 2024-2029년에 8억 2,600만 달러 증가하고, 예측기간 중 CAGR은 6.3%로 성장할 것으로 예측됩니다.
개 관절염 치료 시장의 전체적인 분석, 시장 규모·예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 다룬 벤더 분석 등을 게재하고 있습니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장은개 관절염의 유병률 증가, 반려동물 사육 증가와 반려동물의 인간화, 가처분 소득 증가에 의해 주도되고 있습니다.
| 시장 범위 |
| 기준연도 |
2025 |
| 종료연도 |
2029 |
| 예측 기간 |
2025-2029 |
| 성장 모멘텀 |
가속 |
| 전년대비 |
5.8% |
| CAGR |
6.3% |
| 증가액 |
8억 2,600만 달러 |
본 조사는 업계의 주요 참가자로부터의 인풋을 포함한 1차 정보와 2차 정보의 객관적인 조합을 사용하여 시행했습니다. 리포트에는 주요 기업의 분석과 함께 종합적 시장 규모 데이터, 지역 분석에 의한 부문, 벤더 구도가 포함되어 있습니다. 리포트에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 향후 수년간 개 관절염 치료 시장의 성장을 가속하는 주요 이유 중 하나로개 관절염 치료 옵션의 발전을 꼽았습니다. 또한개 관절염 모니터링 및 치료에 대한 의식의 향상 캠페인과 기술 통합에 대한 관심이 높아지면서 시장 수요가 크게 증가할 것으로 보입니다.
목차
제1장 개요
제2장 Technavio 분석
- 가격·수명주기·고객 구입 바스켓·채택률·구입 기준의 분석
- 인풋의 중요성과 차별화의 요인
- 혼란의 요인
- 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모 2024
- 시장 전망 2024-2029
제5장 시장 규모 실적
- 세계의 개 관절염 치료 시장 2019-2023
- 제품 부문 분석 2019-2023
- 투여 경로 부문 분석 2019-2023
- 유통 채널 부문 분석 2019-2023
- 지역별 부문 분석 2019-2023
- 국가별 부문 분석 2019-2023
제6장 정성 분석
- 미국 관세 전쟁의 영향 분석 : 세계의 개 관절염 치료 시장
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁의 위협
- 시장 현황
제8장 시장 세분화 : 제품별
- 시장 부문
- 비교 : 제품별
- NSAIDs : 시장 규모와 예측 2024-2029
- 오피오이드 : 시장 규모와 예측 2024-2029
- 기타 : 시장 규모와 예측 2024-2029
- 시장 기회 : 제품별
제9장 시장 세분화 : 투여 경로별
- 시장 부문
- 비교 : 투여 경로별
- 경구 : 시장 규모와 예측 2024-2029
- 주사제 : 시장 규모와 예측 2024-2029
- 관절내 주사 : 시장 규모와 예측 2024-2029
- 시장 기회 : 투여 경로별
제10장 시장 세분화 : 유통 채널별
- 시장 부문
- 비교 : 유통 채널별
- 오프라인 : 시장 규모와 예측 2024-2029
- 온라인 : 시장 규모와 예측 2024-2029
- 시장 기회 : 유통 채널별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 지역별 비교
- 북미 : 시장 규모와 예측 2024-2029
- 유럽 : 시장 규모와 예측 2024-2029
- 아시아 : 시장 규모와 예측 2024-2029
- 세계의 기타 지역 : 시장 규모와 예측 2024-2029
- 미국 : 시장 규모와 예측 2024-2029
- 중국 : 시장 규모와 예측 2024-2029
- 인도 : 시장 규모와 예측 2024-2029
- 독일 : 시장 규모와 예측 2024-2029
- 프랑스 : 시장 규모와 예측 2024-2029
- 일본 : 시장 규모와 예측 2024-2029
- 멕시코 : 시장 규모와 예측 2024-2029
- 영국 : 시장 규모와 예측 2024-2029
- 호주 : 시장 규모와 예측 2024-2029
- 한국 : 시장 규모와 예측 2024-2029
- 시장 기회 : 지역 상황별
제13장 촉진요인·과제·기회·억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 촉진요인과 과제의 영향
- 시장의 기회·억제요인
제14장 경쟁 구도
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- American Regent Animal Health
- Bayer AG
- Boehringer Ingelheim International GmbH
- Ceva Sante Animale
- Compana Pet Brands LLC
- Dechra Pharmaceuticals Plc
- Elanco Animal Health Inc.
- Jurox Pty Ltd.
- NexGen Pharmaceuticals
- Norbrook Laboratories Ltd.
- Nutramax Laboratories Inc.
- Vetoquinol SA
- VetStem Biopharma
- Virbac Group
- Zoetis Inc.
제16장 부록
KSA
The canine arthritis treatment market is forecasted to grow by USD 826 mn during 2024-2029, accelerating at a CAGR of 6.3% during the forecast period. The report on the canine arthritis treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of canine arthritis, increasing pet ownership and the humanization of pets, and rising disposable income.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 5.8% |
| CAGR | 6.3% |
| Incremental Value | $826 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's canine arthritis treatment market is segmented as below:
By Product
By Route Of Administration
- Oral
- Injectables
- Intra-articular injection
By Distribution Channel
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the advancement in treatment options for canine arthritis as one of the prime reasons driving the canine arthritis treatment market growth during the next few years. Also, increasing focus on awareness campaigns and integration of technology in monitoring and treatment of canine arthritis will lead to sizable demand in the market.
The report on the canine arthritis treatment market covers the following areas:
- Canine Arthritis Treatment Market sizing
- Canine Arthritis Treatment Market forecast
- Canine Arthritis Treatment Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading canine arthritis treatment market vendors that include American Regent Animal Health, Bayer AG, Boehringer Ingelheim International GmbH, Ceva Sante Animale, Compana Pet Brands LLC, Dechra Pharmaceuticals Plc, Elanco Animal Health Inc., Jurox Pty Ltd., NexGen Pharmaceuticals, Norbrook Laboratories Ltd., Nutramax Laboratories Inc., Thorne Vet., Vetoquinol SA, VetStem Biopharma, Virbac Group, and Zoetis Inc.. Also, the canine arthritis treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Route of Administration
- Executive Summary - Chart on Market Segmentation by Distribution Channel
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Canine Arthritis Treatment Market 2019 - 2023
- Historic Market Size - Data Table on Global Canine Arthritis Treatment Market 2019 - 2023 ($ million)
- 5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
- 5.3 Route of Administration segment analysis 2019 - 2023
- Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
- 5.4 Distribution Channel segment analysis 2019 - 2023
- Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 Impact Analysis of U.S. Tariff War on Global Canine Arthritis Treatment Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
- 8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
- 8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
- 8.3 NSAIDs - Market size and forecast 2024-2029
- Chart on NSAIDs - Market size and forecast 2024-2029 ($ million)
- Data Table on NSAIDs - Market size and forecast 2024-2029 ($ million)
- Chart on NSAIDs - Year-over-year growth 2024-2029 (%)
- Data Table on NSAIDs - Year-over-year growth 2024-2029 (%)
- 8.4 Opioids - Market size and forecast 2024-2029
- Chart on Opioids - Market size and forecast 2024-2029 ($ million)
- Data Table on Opioids - Market size and forecast 2024-2029 ($ million)
- Chart on Opioids - Year-over-year growth 2024-2029 (%)
- Data Table on Opioids - Year-over-year growth 2024-2029 (%)
- 8.5 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
- 8.6 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Route of Administration
- 9.1 Market segments
- Chart on Route of Administration - Market share 2024-2029 (%)
- Data Table on Route of Administration - Market share 2024-2029 (%)
- 9.2 Comparison by Route of Administration
- Chart on Comparison by Route of Administration
- Data Table on Comparison by Route of Administration
- 9.3 Oral - Market size and forecast 2024-2029
- Chart on Oral - Market size and forecast 2024-2029 ($ million)
- Data Table on Oral - Market size and forecast 2024-2029 ($ million)
- Chart on Oral - Year-over-year growth 2024-2029 (%)
- Data Table on Oral - Year-over-year growth 2024-2029 (%)
- 9.4 Injectables - Market size and forecast 2024-2029
- Chart on Injectables - Market size and forecast 2024-2029 ($ million)
- Data Table on Injectables - Market size and forecast 2024-2029 ($ million)
- Chart on Injectables - Year-over-year growth 2024-2029 (%)
- Data Table on Injectables - Year-over-year growth 2024-2029 (%)
- 9.5 Intra-articular injection - Market size and forecast 2024-2029
- Chart on Intra-articular injection - Market size and forecast 2024-2029 ($ million)
- Data Table on Intra-articular injection - Market size and forecast 2024-2029 ($ million)
- Chart on Intra-articular injection - Year-over-year growth 2024-2029 (%)
- Data Table on Intra-articular injection - Year-over-year growth 2024-2029 (%)
- 9.6 Market opportunity by Route of Administration
- Market opportunity by Route of Administration ($ million)
- Data Table on Market opportunity by Route of Administration ($ million)
10 Market Segmentation by Distribution Channel
- 10.1 Market segments
- Chart on Distribution Channel - Market share 2024-2029 (%)
- Data Table on Distribution Channel - Market share 2024-2029 (%)
- 10.2 Comparison by Distribution Channel
- Chart on Comparison by Distribution Channel
- Data Table on Comparison by Distribution Channel
- 10.3 Offline - Market size and forecast 2024-2029
- Chart on Offline - Market size and forecast 2024-2029 ($ million)
- Data Table on Offline - Market size and forecast 2024-2029 ($ million)
- Chart on Offline - Year-over-year growth 2024-2029 (%)
- Data Table on Offline - Year-over-year growth 2024-2029 (%)
- 10.4 Online - Market size and forecast 2024-2029
- Chart on Online - Market size and forecast 2024-2029 ($ million)
- Data Table on Online - Market size and forecast 2024-2029 ($ million)
- Chart on Online - Year-over-year growth 2024-2029 (%)
- Data Table on Online - Year-over-year growth 2024-2029 (%)
- 10.5 Market opportunity by Distribution Channel
- Market opportunity by Distribution Channel ($ million)
- Data Table on Market opportunity by Distribution Channel ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.9 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.10 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.13 Mexico - Market size and forecast 2024-2029
- Chart on Mexico - Market size and forecast 2024-2029 ($ million)
- Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
- Chart on Mexico - Year-over-year growth 2024-2029 (%)
- Data Table on Mexico - Year-over-year growth 2024-2029 (%)
- 12.14 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.15 Australia - Market size and forecast 2024-2029
- Chart on Australia - Market size and forecast 2024-2029 ($ million)
- Data Table on Australia - Market size and forecast 2024-2029 ($ million)
- Chart on Australia - Year-over-year growth 2024-2029 (%)
- Data Table on Australia - Year-over-year growth 2024-2029 (%)
- 12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
- 12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
- 13.1 Market drivers
- 13.2 Market challenges
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities/restraints
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 American Regent Animal Health
- American Regent Animal Health - Overview
- American Regent Animal Health - Product / Service
- American Regent Animal Health - Key offerings
- SWOT
- 15.5 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 15.6 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
- 15.7 Ceva Sante Animale
- Ceva Sante Animale - Overview
- Ceva Sante Animale - Product / Service
- Ceva Sante Animale - Key offerings
- SWOT
- 15.8 Compana Pet Brands LLC
- Compana Pet Brands LLC - Overview
- Compana Pet Brands LLC - Product / Service
- Compana Pet Brands LLC - Key offerings
- SWOT
- 15.9 Dechra Pharmaceuticals Plc
- Dechra Pharmaceuticals Plc - Overview
- Dechra Pharmaceuticals Plc - Business segments
- Dechra Pharmaceuticals Plc - Key offerings
- Dechra Pharmaceuticals Plc - Segment focus
- SWOT
- 15.10 Elanco Animal Health Inc.
- Elanco Animal Health Inc. - Overview
- Elanco Animal Health Inc. - Product / Service
- Elanco Animal Health Inc. - Key offerings
- SWOT
- 15.11 Jurox Pty Ltd.
- Jurox Pty Ltd. - Overview
- Jurox Pty Ltd. - Product / Service
- Jurox Pty Ltd. - Key offerings
- SWOT
- 15.12 NexGen Pharmaceuticals
- NexGen Pharmaceuticals - Overview
- NexGen Pharmaceuticals - Product / Service
- NexGen Pharmaceuticals - Key offerings
- SWOT
- 15.13 Norbrook Laboratories Ltd.
- Norbrook Laboratories Ltd. - Overview
- Norbrook Laboratories Ltd. - Product / Service
- Norbrook Laboratories Ltd. - Key offerings
- SWOT
- 15.14 Nutramax Laboratories Inc.
- Nutramax Laboratories Inc. - Overview
- Nutramax Laboratories Inc. - Product / Service
- Nutramax Laboratories Inc. - Key offerings
- SWOT
- 15.15 Vetoquinol SA
- Vetoquinol SA - Overview
- Vetoquinol SA - Business segments
- Vetoquinol SA - Key offerings
- Vetoquinol SA - Segment focus
- SWOT
- 15.16 VetStem Biopharma
- VetStem Biopharma - Overview
- VetStem Biopharma - Product / Service
- VetStem Biopharma - Key offerings
- SWOT
- 15.17 Virbac Group
- Virbac Group - Overview
- Virbac Group - Business segments
- Virbac Group - Key offerings
- Virbac Group - Segment focus
- SWOT
- 15.18 Zoetis Inc.
- Zoetis Inc. - Overview
- Zoetis Inc. - Business segments
- Zoetis Inc. - Key news
- Zoetis Inc. - Key offerings
- Zoetis Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
